HELP FIGHT CHILDHOOD CANCER

Every week in the UK, around two children are diagnosed with neuroblastoma, an aggressive and life-threatening cancer.

Thanks to you, we’ve funded nearly £9 million of pioneering research to develop new, more effective and less punishing treatments for children with neuroblastoma.

But we need to do more. Donate or get involved to help save young lives.

What is neuroblastoma?

Neuroblastoma is a rare cancer that develops from cells left behind from a baby’s development in the womb. 

Personal stories

A number of families have generously shared their personal experience of neuroblastoma to help others.

Neuroblastoma research

We have invested nearly £9 million into impactful pre-clinical neuroblastoma research to advance our understanding of neuroblastoma, accelerate drug development and improve treatment.

GET INVOLVED

Get involved today and help fund vital research into neuroblastoma.

Choose a challenge, take part in an organised run or do your own thing!

Neuroblastoma Events
Join Team Neuroblastoma UK at the 2025 London Landmarks Half Marathon!
Apr 6
marathon, sporting event
Join Team Neuroblastoma UK at the 2025 London Landmarks Half Marathon!
marathon, sporting event

Are you ready to lace up your running shoes for a cause that truly matters? Neuroblastoma UK invites you to be a part of something incredible – the 2025 London Marathon. Join our team and make every step count in the fight against neuroblastoma.

marathon, sporting event

OUR LATEST NEWS

latest news
North Nottinghamshire Prep School Releases Original Song to Support Neuroblastoma UK.
North Nottinghamshire Prep School Releases Original Song to Support Neuroblastoma UK.

Pupils at Ranby House School in Retford, Nottinghamshire, have released an original song ‘Our Special Story’, in a bid to raise funds for Neuroblastoma UK.

Read More →
New decision-making tool for treatment of relapsed and refractory neuroblastoma 
New decision-making tool for treatment of relapsed and refractory neuroblastoma 

We’re excited to share the launch of a brand-new tool for those navigating treatment pathways for high-risk neuroblastoma. The Redmapp Website is designed to support families facing the difficult decisions that come when their child is faced with uncertainty associated with more complex cases of neuroblastoma.

Read More →
Research partly funded by Neuroblastoma UK leads to an innovative stem cell model providing insight into childhood cancer origins
research
Research partly funded by Neuroblastoma UK leads to an innovative stem cell model providing insight into childhood cancer origins
research

Researchers from the University of Sheffield and St. Anna Children’s Cancer Research Institute have created a model designed to investigate the origins of neuroblastoma, a cancer primarily affecting infants and young children. The findings offer hope for the creation of tailored treatments which treat aggressive neuroblastomas and minimise the adverse effects experienced by patients from existing therapies.

Read More →
research
New research suggests potential combination therapy option for children with neuroblastoma to prevent resistance to treatment
research, latest news
New research suggests potential combination therapy option for children with neuroblastoma to prevent resistance to treatment
research, latest news

New research published by Professor Suzanne Turner and led by Dr Perla Pucci in her group at the University of Cambridge Department of Pathology and CRUK Cambridge Centre Paediatric Cancer Programme, has suggested a new target for combination treatment of neuroblastoma and other cancers alongside ALK tyrosine kinase inhibitors (ALK TKI). Resistance to ALK TKI is a challenge and so additional targets for treatments that can be used in combination with ALK TKI are urgently needed.

Read More →
research, latest news